Senseonics (NYSE:SENS) said today that it inked a global deal to integrate its Eversense continuous glucose monitoring system with Glooko‘s diabetes data management tech.
Users will be able to sync data from their Eversense CGM directly into Glooko’s platform and view historical glucose trends, as well as receive real-time readings from their Eversense mobile app, according to Senseonics.
Get the full story at our sister site, Drug Delivery Business News.
The post Senseonics inks diabetes management deal with Glooko appeared first on MassDevice.
from MassDevice https://ift.tt/2m5GYtt
Cap comentari:
Publica un comentari a l'entrada